Hyderabad Telangana, India

Venugopala Chokkasandra Jayarama Reddy

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Venugopala Chokkasandra Jayarama Reddy: Innovator in Pharmaceutical Composition

Introduction

Venugopala Chokkasandra Jayarama Reddy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the stability and bioavailability of pharmaceutical compositions.

Latest Patents

One of his key patents is titled "Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof." This invention relates to a binder-free stable pharmaceutical composition that includes amorphous canagliflozin or a pharmaceutically acceptable salt or prodrug thereof. The composition is devoid of canagliflozin hemihydrate and demonstrates acceptable chemical stability, polymorphic stability, and a comparative dissolution and bioavailability profile to that of INVOKANA® tablets. Venugopala holds 1 patent for this innovative formulation.

Career Highlights

Venugopala is associated with Aurobindo Pharma Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to leverage his expertise in drug formulation and development, contributing to the advancement of pharmaceutical sciences.

Collaborations

He has collaborated with notable colleagues such as Satyabrata Barik and Sivakumaran Meenakshisunderam, enhancing the research and development efforts within his team.

Conclusion

Venugopala Chokkasandra Jayarama Reddy's contributions to pharmaceutical innovation exemplify the importance of research in developing effective drug formulations. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…